Cytek Biosciences (CTKB) Consolidated Net Income (2020 - 2026)
Cytek Biosciences (CTKB) posted Consolidated Net Income of -$18.9 million for Q1 2026, up 57.14% on a QoQ basis from -$44.0 million in Q4 2025, and down 65.52% year-over-year from -$54.7 million in Q1 2025.
Cytek Biosciences (CTKB) Consolidated Net Income (2020 - 2026) Analysis & Trends
Cytek Biosciences' Consolidated Net Income history runs 7 years deep, the most recent figure standing at -$18.9 million for Q1 2026.
- Quarterly Consolidated Net Income fell 65.52% year-over-year to -$18.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$74.0 million (down 555.85% YoY) and the FY2025 annual result came in at -$66.5 million, down 1005.3% from the prior year.
- Consolidated Net Income was -$18.9 million for Q1 2026 at Cytek Biosciences, up from -$44.0 million in the prior quarter.
- Across five years, Consolidated Net Income topped out at $9.6 million in Q4 2024 and bottomed at -$44.0 million in Q4 2025.
- A 5-year average of -$5.9 million and a median of -$5.5 million in 2025 frame the typical range for Consolidated Net Income.
- Peak annual rise in Consolidated Net Income reached 419.14% in 2022, while the deepest fall reached 2215.69% in 2022.
- Cytek Biosciences' Consolidated Net Income stood at $3.7 million in 2022, then jumped by 48.01% to $5.5 million in 2023, then soared by 74.5% to $9.6 million in 2024, then plunged by 558.49% to -$44.0 million in 2025, then surged by 57.14% to -$18.9 million in 2026.
- Business Quant data shows CTKB's Consolidated Net Income at -$18.9 million in Q1 2026, -$44.0 million in Q4 2025, and -$5.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.33 Bn | 174.04 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 128.11 Bn | 125.23 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 107.76 Bn | 98.54 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 67.95 Bn | 66.50 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 28.43 Bn | 26.14 Bn | 1.98 Bn | 411.00 Mn |
| 7 | Dexcom | 28.31 Bn | 27.20 Bn | 750.30 Mn | 199.50 Mn |
| 8 | Smith & Nephew | 26.77 Bn | 26.19 Bn | - | - |
| 9 | Koninklijke Philips | 25.33 Bn | 22.21 Bn | 2.07 Bn | 273.95 Mn |
| 10 | Cytek Biosciences | 582.39 Mn | 516.69 Mn | 21.25 Mn | -18.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.87 Mn |
| Dec 31, 2025 | -44.03 Mn |
| Sep 30, 2025 | -5.47 Mn |
| Jun 30, 2025 | -5.58 Mn |
| Mar 31, 2025 | -11.40 Mn |
| Dec 31, 2024 | 9.60 Mn |
| Sep 30, 2024 | 957,000.00 |
| Jun 30, 2024 | -10.43 Mn |
| Mar 31, 2024 | -6.19 Mn |
| Dec 31, 2023 | 5.50 Mn |
| Sep 30, 2023 | -6.46 Mn |
| Jun 30, 2023 | -4.40 Mn |
| Mar 31, 2023 | -6.84 Mn |
| Dec 31, 2022 | 3.72 Mn |
| Sep 30, 2022 | 1.63 Mn |
| Jun 30, 2022 | -702,000.00 |
| Mar 31, 2022 | -2.16 Mn |
| Dec 31, 2021 | -1.17 Mn |
| Sep 30, 2021 | 1.42 Mn |
| Jun 30, 2021 | 2.67 Mn |